| S1655 |
Ezetimibe (SCH-58235)
|
Ezetimibe (SCH-58235) 是一種有效的、選擇性的膽固醇吸收抑制劑，用來降低膽固醇。 |
-
J Med Chem, 2025, 68(2):1179-1194
-
Toxicol Lett, 2025, 406:31-37
-
J Immunother Cancer, 2024, 12(11)e009805
|
|
| S8284 |
Fatostatin HBr
|
Fatostatin HBr是固醇調(diào)節(jié)元件結(jié)合蛋白(SREBP)的抑制劑。它抑制SREBP-1和SREBP-2的激活。 |
-
Cancer Commun (Lond), 2025, 10.1002/cac2.70038
-
Cell Commun Signal, 2025, 23(1):438
-
ACS Omega, 2024, 9(47):47042-47051
|
|
| S6418 |
PF 429242
|
PF 429242是S1P抑制劑，IC50為170 nM。在其濃度高達(dá)100 μM時(shí)，PF 429242對胰蛋白酶、彈性蛋白酶、蛋白酶K、胞漿素、激肽釋放酶、factor XIa、凝血酶或弗林蛋白酶沒有顯著抑制作用，而對尿激酶和factor Xa僅具有中等抑制作用。 |
-
Cell Rep, 2023, 42(6):112586
-
Nat Commun, 2019, 11;10(1):4621
|
|
| S9392 |
Praeruptorin B
|
Praeruptorin B is an important compound isolated from Bai-hua Qian-hu and has been reported to exert multiple biochemical and pharmacological activities. |
-
Nat Metab, 2021, 10.1038/s42255-021-00479-4
|
|
| S3798 |
L-Citrulline
|
L-citrulline is a substance called a non-essential amino acid that is used as a sports performance and cardiovascular health supplement. |
|
|
| E8028 |
FGH10019
|
FGH10019 是一種固醇調(diào)節(jié)元件結(jié)合蛋白 (SREBP) 抑制劑，IC50 值為 1 μM。 |
|
|
| S8284 |
Fatostatin HBr
|
Fatostatin HBr是固醇調(diào)節(jié)元件結(jié)合蛋白(SREBP)的抑制劑。它抑制SREBP-1和SREBP-2的激活。 |
- Cancer Commun (Lond), 2025, 10.1002/cac2.70038
- Cell Commun Signal, 2025, 23(1):438
- ACS Omega, 2024, 9(47):47042-47051
|
|
| S6418 |
PF 429242
|
PF 429242是S1P抑制劑，IC50為170 nM。在其濃度高達(dá)100 μM時(shí)，PF 429242對胰蛋白酶、彈性蛋白酶、蛋白酶K、胞漿素、激肽釋放酶、factor XIa、凝血酶或弗林蛋白酶沒有顯著抑制作用，而對尿激酶和factor Xa僅具有中等抑制作用。 |
- Cell Rep, 2023, 42(6):112586
- Nat Commun, 2019, 11;10(1):4621
|
|
| S9392 |
Praeruptorin B
|
Praeruptorin B is an important compound isolated from Bai-hua Qian-hu and has been reported to exert multiple biochemical and pharmacological activities. |
- Nat Metab, 2021, 10.1038/s42255-021-00479-4
|
|
| E8028 |
FGH10019
|
FGH10019 是一種固醇調(diào)節(jié)元件結(jié)合蛋白 (SREBP) 抑制劑，IC50 值為 1 μM。 |
|
|
